Qingzhu Granules
- Generic Name
- Qingzhu Granules
A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty Arthritis
Phase 3
Recruiting
- Conditions
- Gouty Arthritis
- Interventions
- Drug: Qingzhu Granules Placebo
- First Posted Date
- 2023-10-05
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Target Recruit Count
- 472
- Registration Number
- NCT06068478
- Locations
- 🇨🇳
Henan Province Luoyang Orthopedic Hospital, Luoyang, Henan, China
🇨🇳Xinxiang Central Hospital, Xinxiang, Henan, China
Zhengzhou People's Hospital
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath